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Science is about building causal relations between natural
phenomena (for instance, between a mutation in a gene and a
disease). The development of instruments to increase our
capacity to observe natural phenomena has, therefore, played
a crucial role in the development of science - the microscope
being the paradigmatic example in biology. With the human
genome, the natural world takes an unprecedented turn: it is
better described as a sequence of symbols. Besides high-
throughput machines such as sequencers and DNA chip
readers, the computer and the associated software becomes
the instrument to observe it, and the discipline of
bioinformatics flourishes. However, as the separation
between us (the observers) and the phenomena observed
increases (from organism to cell to genome, for instance),
instruments may capture phenomena only indirectly,
through the footprints they leave. Instruments therefore need
to be calibrated: the distance between the reality and the
observation (through the instrument) needs to be accounted
for. This issue of Genome Biology is about calibrating
instruments to observe gene sequences; more specifically,
computer programs to identify human genes in the sequence
of the human genome.
After nearly 25 years of research in the area of
computational gene finding, and genome annotation, and
after the completion of the human genome sequence in
2003, it became important to assess the current state-of-the-
art in this discipline because in the future the success of
many genomic and systems biology projects will depend on
the quality of genome annotations. In this endeavor we built
on the efforts by the NIH initiated ENCODE (for
ENCyclopedia of DNA Elements) project, the goal of which,
in its first phase, is the development and assessment of
methods to identify all functional elements in 1% of the
human genome across 44 regions, so that these methods can
later be applied to the entire human genome. Within this
project, the GENCODE consortium has produced a high
quality annotation of the protein coding content of the
ENCODE regions. We have used this annotation as the
‘golden standard’ against which to measure the performance
of the computational methods. Developing such a standard
has been a difficult task and the paper by Harrow et al. in
this issue is dedicated to describing the process by means of
which the GENCODE standard annotation was obtained.
Scientists working in the field of computational genome
annotation were asked to submit predictions on the
ENCODE regions. Eighteen groups worldwide participated
in the experiment - which we named EGASP (for ENCODE
Genome Annotation Assessment Project), the second of its
kind after GASP1 [1] - and submitted 30 prediction sets
using state-of-the-art methods.
Predictions were compared to the golden standard in a
workshop organized at the Sanger Center on May 6 and 7,
2005, and sponsored by the National Human Genome
Research Institute (NHGRI) at the NIH. The gene finding
evaluation experiment is described in detail in Guigó et al. in
this issue and the promoter evaluation experiment is
described in Bajic et al. Many of the computational gene
finding methods applied are also described in this issue:
Allen  et al., Arumugam and Brent, Carter and Durbin,
Djebali et al., Flicek and Brent, Solovyev et al., Stanke et al.
and Thierry-Mieg and Thierry-Mieg. The paper by Zheng
and Gerstein describes the analysis of the pseudogenes.
The willingness of the scientists within the gene finding
community to provide their computational annotation for
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Freepublic comparison and blind evaluation against one and the
same standard annotation set allowed us to really identify
pluses and minuses in the various methodical approaches.
Too often superior performance is claimed for new datasets
without a careful analysis of potential biases within them.
Therefore, we hope that with this experiment we have again
laid out a test bed for performance enhancement within the
field of gene finding. The difficulty of a repeated experiment
in the future will be that it is hard to distinguish whether
performance has improved due to the more and better
auxiliary data (for example better cDNA sequences) or due to
algorithmic improvements. Therefore, we suggest repeating
the experiment in the future with the same genomic sequence
and using the same, ‘frozen’ auxiliary sequence databases.
Furthermore, we expect that a future experiment would
include a higher focus on multiple mRNA transcript
evaluation, including 5’ and 3’ untranslated region transcript
predictions besides the classic coding sequence evaluations.
EGASP highlighted the recent progress in computational
gene finding. Computer programs are increasingly sophis-
ticated, efficient and accurate in mapping cDNA and protein
sequences onto the genome sequence, as well as in using
genome comparisons to other organisms. Despite the
progress, however, programs are still not able to replace the
insight of human annotators. Difficulties arise not only from
the quality of the source data, but also because of the
complexities of biology and the complex structure of human
genes: the bulk of cDNA sequences are partial, and contain
many sequence errors, and genome sequences are often
incomplete and errors may exist in the assemblies; mapping
of cDNA sequences onto the genome is compounded by the
presence of pseudogenes and recent duplicates, which
occasionally makes it very difficult to identify the exact
genomic locus for a given cDNA sequence; and alternative
splicing, for instance, is widespread, and involves, more
often than until very recently expected, exons from
apparently different loci. The diversity of the human
proteome may be much higher than that derived simply
from the total number of genes.
Computational methods at EGASP also predicted many
exons and genes that were not included in the standard
GENCODE annotation. While predictions mapped within
annotated loci could correspond to novel alternative splice
forms of known genes, predictions in intergenic regions
might reveal novel genes. However, only a handful of such
predictions could be verified by RT-PCR experiments using
24 human tissue libraries. This certainly seems to suggest
that the standard GENCODE annotation is quite complete,
and that, in general, not many novel gene loci remain to be
discovered in the sequence of the human genome. This is,
however, in contrast with results from recent large-scale
surveys of the transcriptional activity of the human genome
using high-throughput sequencing and hybridization based
technologies [2].These reveal, also in the ENCODE regions,
a wealth of sites of transcription that are neither included in
the standard annotation or predicted by the programs.
Whether these correspond to real, novel, protein coding
genes or to non-coding RNAs could not be answered within
the project described here.
In summary, from the EGASP project we have learnt that the
current human genome annotation is almost complete in
terms of novel protein coding loci. Nevertheless, the
annotation of the exact structure and the transcriptional
organization of a gene is still nowhere near completed. Three
years after the completion of the human genome sequence
and after all the human chromosomes have been published it
seems that the gene locus annotations are still in flux.
Therefore, we believe that efforts towards annotating the
human genome should be extended. Almost correct gene
annotations are simply not good enough as the blueprint of
human biology. These errors can mislead many follow-on
projects such as genetic variation experiments, mRNA
expression profiling as well as proteomic experiments.
Efforts to systematically and continuously sequence high-
quality cDNA libraries to obtain full-length cDNA sequences,
such as those at the Mammalian Gene Collection [3] need to
be continued, although increasingly aggressive sequencing
of cDNA libraries appears to have reached a plateau and is
yielding only a fraction (which could be small) of lowly or
rarely expressed transcripts. Hybridization based tech-
niques, such as high density genome tiling micro-arrays,
could constitute, in this regard, a complementary approach.
The ultimate goal in human genome annotation should be to
map onto the genome sequence all primary and processed
RNA molecules that exist in a given cell type at a given time -
and ideally measure their relative abundance. This is a task
that will likely take at least a decade to achieve completely.
While the biological roles of non-coding RNAs are
increasingly appreciated, EGASP focused on protein coding
genes. In this regard, EGASP has shown that computational
methods do not provide evidence for many additional, still
un-annotated protein coding genes in the human genome,
and, therefore, there is no need to drastically re-evaluate the
current estimations of the total number of human genes.
Current annotation efforts within the ENCODE project, in
which RACE reactions are hybridized into genome tiling
arrays, have, however, uncovered a wealth of additional
transcripts mapping onto annotated protein coding loci.
Often these transcripts reach upstream genes and include
exons from intervening loci. These transcriptional
continuums, in which boundaries between loci seem to fade
away, challenge our very concept of what a gene is, and
makes estimating the total number of human genes almost a
futile task.
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